Different Prognostic Patterns in Epilepsies and Considerations About the Denotations of Atypical Patterns
- PMID: 35317501
- PMCID: PMC8895800
- DOI: 10.29399/npa.27976
Different Prognostic Patterns in Epilepsies and Considerations About the Denotations of Atypical Patterns
Abstract
Epilepsy is a dynamic and heterogeneous neurological disease, and in long-term studies on prognosis, classically 5 basic patterns (early remission, late remission, relapsing-remitting, worsening, and non-remitting) have been identified. The most frequent pattern was relapsing-remitting course, and factors such as the presence of genetic etiology, rare seizures at the beginning of epilepsy and the absence of psychiatric comorbid diseases were found to be related with this pattern as well as reaching 5 years of remission in the follow-ups. Anti-seizure drug resistance (ASD-R) and factors affecting the presence of this resistance (such as symptomatic etiology, abnormal electroencephalographic findings, having multiple seizure types together, status epilepticus and febrile seizure history) decrease the chance of remission, while idiopathic/genetic etiology, generalized epilepsy, and absence of comorbid diseases seem to be associated with achieving long-term remission. Apart from these basic course patterns, there are some patients with an "atypical prognosis" such as drug-resistant juvenile myoclonic epilepsy (JME), benign hippocampal sclerosis-related mesial temporal lobe epilepsy (HS-MTLE), and severe childhood epilepsy with centro-temporal spikes (CESTS), in which the pathophysiological mechanisms underlying these patterns have not been clarified despite the suggestions of various hypotheses. The presence of comorbid diseases such as hormonal factors (as in catamenial epilepsy), autoimmune processes, thyroid disorders and metabolic and psychiatric diseases may also cause an atypical prognostic pattern by affecting the course of the disease. In this review, our aim is to provide the clinician with an up-to-date and questioning perspective on the prognostic markers of epilepsy, by examining in detail some specific epilepsy syndromes that may show atypical prognosis as well as the general prognostic features of epilepsy.
Keywords: Epilepsy; atypical prognosis; drug resistance; prognosis; relapse; remission.
Copyright: © 2022 Turkish Neuropsychiatric Society.
Conflict of interest statement
Conflict of Interest: The authors have no conflict of interest.
Figures



Similar articles
-
Seizure outcome following medical treatment of mesial temporal lobe epilepsy: Clinical phenotypes and prognostic factors.Clin Neurol Neurosurg. 2016 May;144:91-5. doi: 10.1016/j.clineuro.2016.03.018. Epub 2016 Mar 24. Clin Neurol Neurosurg. 2016. PMID: 27037863
-
Prognostic patterns and predictors in epilepsy: a multicentre study (PRO-LONG).J Neurol Neurosurg Psychiatry. 2019 Nov;90(11):1276-1285. doi: 10.1136/jnnp-2019-320883. Epub 2019 Jun 27. J Neurol Neurosurg Psychiatry. 2019. PMID: 31248935
-
Seizure outcome trajectories in a well-defined cohort of newly diagnosed juvenile myoclonic epilepsy patients.Acta Neurol Scand. 2022 Mar;145(3):314-321. doi: 10.1111/ane.13556. Epub 2021 Nov 17. Acta Neurol Scand. 2022. PMID: 34791656
-
MTLE with hippocampal sclerosis in adult as a syndrome.Rev Neurol (Paris). 2015 Mar;171(3):259-66. doi: 10.1016/j.neurol.2015.02.004. Epub 2015 Feb 26. Rev Neurol (Paris). 2015. PMID: 25727907 Review.
-
Surgery for epilepsy.Cochrane Database Syst Rev. 2019 Jun 25;6(6):CD010541. doi: 10.1002/14651858.CD010541.pub3. Cochrane Database Syst Rev. 2019. PMID: 31237346 Free PMC article.
References
-
- Onal AE, Tumerdem Y, Ozturk MK, Gurses C, Baykan B, Gokyigit A, et al. Epilepsy prevalence in a rural area in Istanbul. Seizure. 2002;11:397–401. - PubMed
-
- Beghi E. Addressing the burden of epilepsy: Many unmet needs. Pharmacol Res. 2016;107:79–84. - PubMed
-
- Thijs RD, Surges R, O'Brien TJ, Sander JW. Epilepsy in adults. Lancet. 2019;393:689–701. - PubMed
Publication types
LinkOut - more resources
Full Text Sources